Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 3 1

Status

Completed 164Unknown 39Recruiting 20Terminated 19Not yet recruiting 11Withdrawn 9Active not recruiting 6Enrolling by invitation 5

Sponsor Class

OTHER 6

Study Type

Interventional 6Observational 4

Sponsor

Cancer Type

Gynecologic 6

Conditions

Breast Neoplasms 705Carcinoma, Non-Small-Cell Lung 472Prostatic Neoplasms 420Neoplasms 379Multiple Myeloma 261Colorectal Neoplasms 261Lung Neoplasms 248Neoplasm Metastasis 230Melanoma 215Ovarian Neoplasms 191Leukemia, Myeloid, Acute 190Pancreatic Neoplasms 181Squamous Cell Carcinoma of Head and Neck 163Recurrence 146Carcinoma, Renal Cell 144Lymphoma 142Glioblastoma 138Lymphoma, Non-Hodgkin 134Stomach Neoplasms 129Triple Negative Breast Neoplasms 127Carcinoma, Hepatocellular 123Brain Neoplasms 123Leukemia, Lymphocytic, Chronic, B-Cell 122Uterine Cervical Neoplasms 117Head and Neck Neoplasms 117Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Urinary Bladder Neoplasms 113Lymphoma, Large B-Cell, Diffuse 105Sarcoma 102Lymphoma, Follicular 100

Interventions

human papillomavirus vaccine, L1 type 16, 18 1Molecular Diagnostic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Uterine Cervical Dysplasia × Clear all
NCT02328872 2026-04-17

Compass

VCS Foundation

Phase NA Active not recruiting
76,181 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT06810427 2026-03-18

CervImage

Carilion Clinic

Phase NA Active not recruiting
18 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT04537156 2025-11-21

Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Xiamen University

Phase 3 Active not recruiting
9,327 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Condylomata Acuminata

NCT06582004 2025-11-19

Comparisons of the Effects and Clinical Outcomes of CH2 Vaginal Gel Versus Placebo on CIN1

National Taiwan University Hospital

Phase NA Active not recruiting
50 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT05996783 2025-06-13

ScreenUrSelf

Universiteit Antwerpen

Phase NA Active not recruiting
48,000 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT06452004 2025-04-04

AI-DSS

University Medical Center Groningen

Phase NA Active not recruiting
600 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡